• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Meta-analysis details short-term outcomes of SARS-CoV-2 mRNA vaccine-associated myopericarditis in adolescents and young adults

byVincent SoandAlex Gipsman, MD
January 3, 2023
in Cardiology, Emergency, Infectious Disease, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a systematic review and meta-analysis of COVID vaccine-associated myopericarditis in adolescents and young adults, short-term outcomes were generally favorable.

2. Hospitalization for COVID vaccine-associated myopericarditis was associated with a short length of stay, rarely required inotropic support, and was not associated with death.

Evidence Rating Level: 2 (Good)

Study Rundown: COVID mRNA vaccine-associated myopericarditis is a rare but serious adverse event that has been reported in young adults and adolescents. In adults, vaccine-related myocarditis typically resolves with minimal complications and preservation of cardiac function. However, clinical outcomes of COVID vaccine-associated myopericarditis have not been well studied in adolescents and young adults. This systematic review and meta-analysis investigated early outcomes associated with myopericarditis after COVID vaccination in children and young adolescents aged 12-20 years old. In general, myopericarditis occurred more frequently after the second dose of the COVID vaccine and was almost exclusively seen in males. Nearly all patients with myopericarditis were hospitalized, with an average length of stay of 2.8 days. About 15% of patients with myopericarditis had decreased left ventricular (LV) systolic function, although roughly 1% had severe LV dysfunction. In addition, vaccine-associated myopericarditis was not associated with death or the use of mechanical respiratory support. The most significant limitation of this study is the lack of long-term follow-up information regarding complications from vaccine-associated myopericarditis  In general, this study suggests that vaccine-associated myopericarditis is rare and that short-term outcomes are favorable; however, larger studies with longer follow-up periods are necessary to further inform our understanding of this condition.

Click here to read the article in JAMA Pediatrics

Relevant Reading: Myocarditis after RNA-based vaccines for coronavirus

In-Depth [systematic review and meta-analysis]: This systematic review and meta-analysis included all observational studies from inception to August 25, 2022, describing myopericarditis after COVID-19 vaccination. 1406 potential articles were identified, with 23 articles included in the systematic review and 12 studies included in a meta-analysis. The incident rate of COVID vaccine-associated myopericarditis was higher after the second dose of the vaccine compared to the first, with 74.4% (95%CI, 58.2%-90.5%) of total events occurring after the second dose. Common symptoms included chest pain (83.7% of patients [95% CI, 72.7-94.6], p<0.001), fever (44.5% of patients [95% CI, 16.9-72.0, p<0.001], and headache (33.3% of patients [95% CI, 8.6-58.0, p<0.001]. The most common markers of myopericarditis included elevated troponin in 84.5% (95% CI, 75.1%-94.5%) of patients and ST-segment elevation or depression in 53.0% (95% CI, 34.6%-71.3%) of patients. Most patients had preserved LV systolic function (84.4% of patients [95%CI, 80.5%-88.3%]). Overall, 92.6% (95%CI, 87.8%-97.3%) of patients required hospitalization, with 23.2% (95% CI, 11.7%-34.7%) requiring ICU admission. Despite ICU admissions, only 1.3% (95%CI, 0%-2.7%) of patients required inotropic support, with no deaths or mechanical ventilation, and had an average length of stay of 2.8 days (95%CI, 2.1-3.5).

RELATED REPORTS

Nirmatrelvir-ritonavir combination reduces hospitalization and mortality in COVID-19

Online cooking education may improve perceived cooking and motor competencies in children

BNT162b2 booster is safe and reduces COVID-19 transmission in older adults

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: COVID-19COVID-19 VaccineMyocarditismyopericarditisvaccine side effects
Previous Post

Return to sport following COVID-19 may improve adolescent athlete wellbeing

Next Post

Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis

RelatedReports

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies
Emergency

Nirmatrelvir-ritonavir combination reduces hospitalization and mortality in COVID-19

February 1, 2023
Eating in the absence of hunger linked to toddler obesity
Lifestyle

Online cooking education may improve perceived cooking and motor competencies in children

January 31, 2023
Social networks play key roles in parental vaccination decisions
Infectious Disease

BNT162b2 booster is safe and reduces COVID-19 transmission in older adults

January 30, 2023
Evidence-based interventions for pediatric asthma successfully adapted for community health centers
Weekly Rewinds

2 Minute Medicine Rewind January 23, 2023

January 30, 2023
Next Post
Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]

Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis

#VisualAbstract: Haloperidol provides no additional benefit for the management of delirium in patients admitted to the ICU

#VisualAbstract: Haloperidol provides no additional benefit for the management of delirium in patients admitted to the ICU

Few high school students, young adults get HIV testing

Risk scores perform moderately well in discriminating people living with HIV with higher vs lower cardiovascular disease risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Concordance of diagnosis of autism spectrum disorder made by pediatricians vs multidisciplinary specialist teams
  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
  • #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options